A detailed history of Vista Investment Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vista Investment Partners LLC holds 2,118 shares of GILD stock, worth $227,939. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,118
Holding current value
$227,939
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 17, 2025

BUY
$89.14 - $117.41 $188,798 - $248,674
2,118 New
2,118 $237 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $135B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Vista Investment Partners LLC Portfolio

Follow Vista Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vista Investment Partners LLC with notifications on news.